United States trademark law

Former Acting General Counsel of the USPTO Nicholas Matich Joins McKool Smith

Retrieved on: 
Friday, December 11, 2020
Intellectual property law, United States trademark law, McKool Smith, United States Patent and Trademark Office, Patent attorneys, United States patent law, David Kappos

NEW YORK, Dec. 11, 2020 /PRNewswire/ --McKool Smith, one of the nation's leading trial firms, has announced that Nicholas Matich , former Acting General Counsel of the United States Patent and Trademark Office (USPTO), will join the firm as a principal in its intellectual property practice.

Key Points: 
  • NEW YORK, Dec. 11, 2020 /PRNewswire/ --McKool Smith, one of the nation's leading trial firms, has announced that Nicholas Matich , former Acting General Counsel of the United States Patent and Trademark Office (USPTO), will join the firm as a principal in its intellectual property practice.
  • Prior to assuming the role of Acting General Counsel, Mr. Matich served as Senior Legal Advisor in the Office of the USPTO Director, in which capacity he personally briefed and argued a number of high stakes appeals on behalf of the USPTO.
  • Prior to working at the USPTO, Mr. Matich was Deputy General Counsel at the Office of Management and Budget (OMB) within the Executive Office of the President.
  • McKool Smith represents clients in complex commercial litigation, insurance recovery, intellectual property, bankruptcy, and white collar defense matters.

HealthVerity Awarded U.S. Patent for Privacy-Preserving Analysis for Secure Multi-Party Computing

Retrieved on: 
Wednesday, December 9, 2020
Intellectual property law, United States trademark law, Articles, United States Patent and Trademark Office, Privacy, Medical privacy, Internet privacy, Patent and Trademark Office

PHILADELPHIA, Dec. 9, 2020 /PRNewswire/ --HealthVerity, the leader in privacy-protected data exchange, announced today that the U.S. Patent and Trademark Office ("USPTO") issued U.S. Pat.

Key Points: 
  • PHILADELPHIA, Dec. 9, 2020 /PRNewswire/ --HealthVerity, the leader in privacy-protected data exchange, announced today that the U.S. Patent and Trademark Office ("USPTO") issued U.S. Pat.
  • 10,824,738 on November 3, 2020 in support of HealthVerity's privacy-preserving technology that enables analysis and correlation of disparate datasets for cohorts of interest while preserving individual privacy.
  • "Traditional research has been hindered by the inability to link healthcare data with social determinants of health in a HIPAA-compliant manner," said Andrew Kress, CEO of HealthVerity.
  • This patent is the latest award by the USPTO to HealthVerity in the area of privacy preservation, preceded by U.S. Pat.

UPDATE: GBT Filed for Continuation of its 3D Monolithic Multi-Dimensional/Plane, Memory Structure - Integrated Circuits – Granted

Retrieved on: 
Thursday, December 3, 2020
Intellectual property law, United States patent law, United States Patent and Trademark Office, United States trademark law, Continuing patent application, Patent, Intel

The continuation application has been assigned serial number 17102928 by the USPTO.

Key Points: 
  • The continuation application has been assigned serial number 17102928 by the USPTO.
  • The goal of the continuation application is to strengthen and broaden the protection of the intellectual property.
  • The patent seeks to cover new silicon manufacturing structure and orientation, with the stated designed of providing more capabilities and lower power consumption with reduced cost.
  • These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

Adverty is granted US patent for in-game ad viewability technology BrainImpression™

Retrieved on: 
Tuesday, November 24, 2020
Marketing, Intangible assets, Intellectual property law, Digital marketing, United States Patent and Trademark Office, United States trademark law, Online advertising, Patent, Advertising, Trademark

STOCKHOLM, Nov. 24, 2020 /PRNewswire/ -- Adverty AB (publ) has been granted a patent by the United States Patent and Trademark Office for its in-game ad viewability technology BrainImpression; a groundbreaking method for determining ad viewability and impressions within complex gaming environments.

Key Points: 
  • STOCKHOLM, Nov. 24, 2020 /PRNewswire/ -- Adverty AB (publ) has been granted a patent by the United States Patent and Trademark Office for its in-game ad viewability technology BrainImpression; a groundbreaking method for determining ad viewability and impressions within complex gaming environments.
  • Adverty, the leading in-game platform for advertisers, agencies and game developers, today announces the notice of allowance for its in-game ad viewability technology patent by the United States Patent and Trademark Office.
  • The technology, called BrainImpression, is a groundbreaking method for determining ad viewability and ad impressions, for example, when an advert is considered as seen by the user, within complex computer-generated graphical environments such as two-dimensional and three-dimensional games.
  • To help advertisers understand and publishers define how to count an ad as seen, the media industry has established standards on how to measure web-based ad viewability.

GTX Corp Reports Third Quarter 2020 Financial Results and Corporate Summary Update

Retrieved on: 
Tuesday, November 17, 2020
Intellectual property law, Intangible assets, Patent law, United States Patent and Trademark Office, United States trademark law, Patent, License, Trademark

GTX showed a net profit for Q1, Q2 and Q3 of 2020.

Key Points: 
  • GTX showed a net profit for Q1, Q2 and Q3 of 2020.
  • For the third quarter 2020, we saw a 7% increase in revenues and showed a net profit of slightly over $33k.
  • During the third quarter of 2020, GTX was issued a new patent by the United States Patent and Trademark Office (USPTO), U.S Patent No.
  • On the IP licensing front, during the third quarter 2020, we did not sign any new IP licensing agreements.

Super League Gaming Secures Additional Patent for its Multi-User Game System Technology

Retrieved on: 
Monday, November 16, 2020
Intellectual property law, United States Patent and Trademark Office, United States trademark law, Patent

This most recent patent covers Super Leagues unique and scalable cloud-based camera character technology.

Key Points: 
  • This most recent patent covers Super Leagues unique and scalable cloud-based camera character technology.
  • This is yet another exciting step forward in fulfilling our goal of building out Super Leagues IP, says Ann Hand, Super League Chairman and CEO.
  • This technology provides for scale, and gives us the ability to share all the fast-paced gaming action our audience is craving.
  • Currently, Super League has several additional patents in various stages of review with the USPTO.

TrustyIP receives Gold Special Award from the 4th World Invention Academic Conference (WIAC 2020)

Retrieved on: 
Wednesday, November 11, 2020
Intellectual property law, Articles, Patent law, Intellectual property organizations, Patent offices, United States Patent and Trademark Office, United States trademark law, Patent, Invention, First to file and first to invent

ZEPHYR COVE, Nev., Nov.11, 2020 /PRNewswire-PRWeb/ -- TrustyIP announced today that it received the Gold Special Award in the 4th World Invention Academic Conference (WIAC 2020) by the WIAC organizing committee and Korea Invention News (KINEWS), the leading international awards organization honoring excellence on international inventions.

Key Points: 
  • ZEPHYR COVE, Nev., Nov.11, 2020 /PRNewswire-PRWeb/ -- TrustyIP announced today that it received the Gold Special Award in the 4th World Invention Academic Conference (WIAC 2020) by the WIAC organizing committee and Korea Invention News (KINEWS), the leading international awards organization honoring excellence on international inventions.
  • Mr. Soung-Mo Hong, President of KINEWS, congratulated TrustyIP on the results of the review and evaluation.
  • The USPTO's First-To-File system grants patent rights to those who swiftly file regardless of the invention or conception date.
  • "We designed TrustyIP to address roadblock issues that prevent you or your team from protecting your intellectual properties from our experience writing and prosecuting patent applications.

Hunt Perovskite Technologies Adds Another Key Patent In Perovskite Durability Via Ink Chemistry

Retrieved on: 
Monday, November 2, 2020
Intellectual property law, Patent offices, United States Patent and Trademark Office, United States trademark law, Patent application, Patent

DALLAS, Nov. 2, 2020 /PRNewswire/ --Hunt Perovskite Technologies (HPT) today announced that it has been granted another patent by the United States Patent and Trademark Office (USPTO).

Key Points: 
  • DALLAS, Nov. 2, 2020 /PRNewswire/ --Hunt Perovskite Technologies (HPT) today announced that it has been granted another patent by the United States Patent and Trademark Office (USPTO).
  • This latest patent (US10,741,779) relates to HPT's ongoing work to improve metal halide perovskite material durability through advanced ink chemistry technology and processing.
  • HPT currently owns the largest perovskite PV patent portfolio in the United States and one of the largest in the world.
  • With this newest addition, HPT now has 22 patents granted by the USPTO and over 43 additional patents by various foreign patent offices, along with dozens of pending applications in four key areas, including: Materials-Level Durability, Device-Level Durability, Ink Chemistry, and Processing.

Allarity Therapeutics Gains Allowance from U.S. Patent and Trademark Office for New DRP® Biomarker Patents

Retrieved on: 
Monday, October 26, 2020
Intellectual property law, Branches of biology, Biology, Biomarkers, United States Patent and Trademark Office, United States trademark law, Patent

Hrsholm, Denmark (26 October 2020) Allarity Therapeutics A/S (Allarity or the Company) today announced that the United States Patent and Trademark Office (USPTO) has issued Notices of Allowance to the Company for three new DRP biomarker patents in conjunction with use of several of its clinical pipeline drugs.

Key Points: 
  • Hrsholm, Denmark (26 October 2020) Allarity Therapeutics A/S (Allarity or the Company) today announced that the United States Patent and Trademark Office (USPTO) has issued Notices of Allowance to the Company for three new DRP biomarker patents in conjunction with use of several of its clinical pipeline drugs.
  • The USPTO has issued Notices of Allowance to the Company on the following three patent applications:
    U.S. Patent Application No.
  • The allowance and imminent issuance of these three new DRP biomarker patents further expands Allaritys patent portfolio on unique, drug-specific DRP biomarkers developed with its best-in-class and highly validated DRP platform technology.
  • The Company has now gained allowance and/or issuance of patents on more than 60 different DRP biomarkers.

Practising Law Institute and Foundation for Advancement of Diversity in IP Law Make Essential Patent Office Exam Course Available Free to Scholars

Retrieved on: 
Wednesday, October 14, 2020
Intellectual property law, Patent offices, International Searching and Preliminary Examining Authorities, Intellectual property organizations, United States Patent and Trademark Office, United States trademark law, Patent office, Patent, Outline of patents

"The Foundation is grateful to PLI for its most generous contribution to our Scholar program," says FADIPL President Terry Rea.

Key Points: 
  • "The Foundation is grateful to PLI for its most generous contribution to our Scholar program," says FADIPL President Terry Rea.
  • Taken by more than a thousand law students and professionals each year, PLI's Patent Office Exam Course is recognized as the leading resource for those preparing for a career in IP law.
  • The comprehensive, authoritative, interactive course focuses on the subjects and strategies needed to pass the Patent Office Registration Exam.
  • In addition to the complimentary course, the Foundation covers all registration-related fees for the United States Patent and Trademark Office Patent Bar Examination for Scholars.